News from apitope A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 24, 2018, 04:22 ET Apitope Announces Management Changes

Keith Martin to retire as CEO, continue as Non-Executive Director Hayley French appointed COO and interim CEO Apitope, a clinical stage biotech...


Apr 16, 2018, 03:30 ET Apitope Announces Positive Results with Novel Treatment for Graves' Disease

Phase I data show early efficacy in the majority of patients and a very favourable safety profile Apitope, a clinical stage biotech company...


Feb 21, 2017, 03:00 ET Apitope Announces Positive ATX-MS-1467 Phase IIa Data in Relapsing Multiple Sclerosis

ATX-MS-1467 Reduced the Number and Volume of Brain Lesions With a Very Promising Safety Profile Apitope, the drug discovery and development company...


Oct 26, 2016, 04:00 ET Apitope Announces Enrolment of First Patient in Phase I Trial of ATX-GD-59 for the Treatment of Graves' Disease

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the first...


Nov 25, 2014, 06:16 ET Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the Treatment of Haemophilia A

Treatment for haemophilia A patients developing Factor VIII inhibitors Apitope, the drug discovery and development company focused on...


Sep 04, 2014, 11:21 ET Apitope Treatment Approach Published in Nature Communications

Scientists discover how to 'switch off' autoimmune diseases Apitope, the drug discovery and development company focused on disease-modifying...


Jun 19, 2014, 03:00 ET Apitope Progresses Graves' Disease Treatment

Initiates Preclinical Development of Peptide Therapy Apitope, the drug discovery and development company focused on disease-modifying treatments for...